Intravenous artesunate
Sponsors
U.S. Army Medical Research and Development Command, Makerere University, Georgetown University, University of Oxford, Infectious Diseases Institute, Makerer University College of Health Sciences
Conditions
MalariaMalaria, CerebralSevere MalariaSolid TumorsTuberculosis
Malaria
Phase 1
Study of the Safety of Intravenous Artesunate
CompletedNCT00292929
End: 2006-10-31Target: 40Updated: 2016-10-26
Study of the Safety of Intravenous Artesunate
CompletedNCT00292942
Start: 2006-06-12End: 2008-01-31Updated: 2018-10-25
Phase I Study of Intravenous Artesunate for Solid Tumors
CompletedNCT02353026
Start: 2015-01-31End: 2015-12-31Updated: 2016-11-18
Phase 2
Unknown Phase
Pharmacokinetics and Pharmacodynamics of Intravenous Artesunate for Severe Malaria Treatment
NCT01122134
Start: 2010-05-31End: 2010-09-30Target: 20Updated: 2010-05-13
ARTEM-TB STUDY
Active, not recruitingPACTR201302000483287
Start: 2013-01-31Target: 36Updated: 2026-09-14
Probiotic adjunctive therapy in children with severe malaria
RecruitingPACTR202605540438627
Start: 2024-03-04Target: 128Updated: 2026-09-14